BioAdvance
Finance · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 W Elm St Ste 330, Conshohocken, Penn...Phone Number
(610) 230-0544Website
www.bioadvance.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioAdvance
BioAdvance Capital is an investment firm focused on early-stage life-science companies in the Mid-Atlantic region, aiming to improve human health and quality of life. The company operates as an evergreen fund, maintaining a long-term investment perspective. Their portfolio has successfully attracted over $4.4 billion in external capital to support the growth of its companies. BioAdvance Capital primarily targets clients in the life-science sector with innovative solutions for enhancing well-being.Explore more
BioAdvance Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioAdvance your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BioAdvance
BioAdvance, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioAdvance is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BioAdvance recently announced quarterly report
Check if BioAdvance has recently received funding, and reach out quickly before it becomes old news!
Click to see if BioAdvance had a recent Job posting/layoffs
Product Launch: Get notified when BioAdvance launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BioAdvance has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to BioAdvance
Compare insights from companies similar to BioAdvance, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioAdvance is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
BioAdvance is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about BioAdvance.
BioAdvance Tech Stack
A closer look at the technologies used by BioAdvance
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
BioAdvance News & Media
KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded ...
KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway,KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million
SEATTLE--(BUSINESS WIRE)--KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway, today announces the strengthening of its financial resources through multiple grant awards and expansion of its previously announced Series A financing. The expanded financing was led by Accelerator Life Science Partners (ALSP), who also provided Series A funding for KayoThera. With the additional $5.2 million in new equSenzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test
The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samplesBioAdvance Breaks Life Sciences Investing Record Year in 2022
Nearly $5 million invested in eight new promising Mid-Atlantic life sciences companies PHILADELPHIA, Nov. 9, 2022 /PRNewswire/ -- BioAdvance, a leading venture investor in therapeutics, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region, today announced...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioAdvance
Sign Up For FreeTo access detailed company insights
BioAdvance Capital is an investment firm focused on early-stage life-science companies in the Mid-Atlantic region, aiming to improve human health and quality of life. The company operates as an evergreen fund, maintaining a long-term investment perspective. Their portfolio has successfully attracted over $4.4 billion in external capital to support... Read More
